Related Articles
The effects of PC-Spes on chemosensitive and chemoresistant head and neck cancer cells and primary mucosal keratinocytes
Validation of gefitinib effectiveness in a broad panel of head and neck squamous carcinoma cells
High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma
Co-treatment of wild‑type EGFR head and neck cancer cell lines with afatinib and cisplatin
Down-regulation of MMP-2 expression due to inhibition of receptor tyrosine kinases by imatinib and carboplatin in HNSCC